Intellia Therapeutics Current Ratio 2015-2018 | NTLA

Current and historical current ratio for Intellia Therapeutics (NTLA) from 2015 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Intellia Therapeutics current ratio for the three months ending June 30, 2018 was 12.62.
Intellia Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-06-30 $0.32B $0.03B 12.62
2018-03-31 $0.34B $0.03B 13.20
2017-12-31 $0.36B $0.03B 11.32
2017-09-30 $0.23B $0.03B 8.88
2017-06-30 $0.25B $0.03B 9.33
2017-03-31 $0.26B $0.03B 10.48
2016-12-31 $0.28B $0.03B 9.15
2016-09-30 $0.29B $0.02B 12.93
2016-06-30 $0.30B $0.02B 14.01
2016-03-31 $0.07B $0.01B 6.02
2015-12-31 $0.08B $0.01B 7.26
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.00B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.01B $0.00B 4.31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.064B $0.026B
Intellia Therapeutics is a leading genome editing company, focused on developing therapeutics utilizing a biological tool known as CRISPR-Cas9 system. It believes the CRISPR-Cas9 technology has the potential to transform medicine by permanently editing disease-associated genes in the human body with a single treatment course. The Cas9 protein acts like a pair of molecular scissors that initiates the natural cellular repair process to knockout, repair or insert a gene. The guide RNA sequence recognizes and directs the Cas9 to a specific target deoxyribonucleic acid (DNA) sequence. The Company's sentinel in vivo programs focus on the use of Lipid Nanoparticle (LNPs) for delivery of the CRISPR/Cas9 complex to the liver. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR-Cas9 technology and create a new class of therapeutic products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.969B 15.03
Gilead Sciences (GILD) United States $98.924B 10.98
Biogen (BIIB) United States $68.211B 14.46
Celgene (CELG) United States $59.279B 11.84
Illumina (ILMN) United States $48.007B 60.14
Vertex Pharmaceuticals (VRTX) United States $47.394B 107.82
Regeneron Pharmaceuticals (REGN) United States $43.062B 24.21
Alexion Pharmaceuticals (ALXN) United States $28.459B 21.39
BioMarin Pharmaceutical (BMRN) United States $18.826B 0.00
Incyte (INCY) United States $13.798B 463.64
Seattle Genetics (SGEN) United States $11.870B 0.00
Sarepta Therapeutics (SRPT) United States $9.208B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.346B 0.00
Exact Sciences (EXAS) United States $8.279B 0.00
QIAGEN (QGEN) Netherlands $8.018B 26.22
Bluebird Bio (BLUE) United States $7.068B 0.00
Bio-Techne Corp (TECH) United States $7.000B 46.82
BeiGene (BGNE) Cayman Islands $6.811B 0.00
Alkermes (ALKS) Ireland $6.573B 0.00
Amarin (AMRN) Ireland $5.881B 0.00
Galapagos (GLPG) Belgium $5.281B 0.00
Exelixis (EXEL) United States $5.043B 16.43
Ligand Pharmaceuticals (LGND) United States $4.450B 39.42
Immunomedics (IMMU) United States $3.989B 0.00
Myriad Genetics (MYGN) United States $3.383B 35.94
Ultragenyx Pharmaceutical (RARE) United States $3.320B 0.00
Array BioPharma (ARRY) United States $3.279B 0.00
Horizon Pharma Public (HZNP) Ireland $3.203B 18.13
Intercept Pharmaceuticals (ICPT) United States $3.182B 0.00
Emergent Biosolutions (EBS) United States $3.176B 25.30
Blueprint Medicines (BPMC) United States $3.163B 0.00
GUARDANT HEALTH (GH) United States $3.152B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.068B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.865B 0.00
Ascendis Pharma (ASND) Denmark $2.664B 0.00
Halozyme Therapeutics (HALO) United States $2.605B 34.71
ARGENX SE-ADR (ARGX) Netherlands $2.519B 0.00
Repligen (RGEN) United States $2.479B 83.22
China Biologic Products (CBPO) China $2.459B 16.91
Genomic Health (GHDX) United States $2.423B 135.16
Amicus Therapeutics (FOLD) United States $2.417B 0.00
Acceleron Pharma (XLRN) United States $2.385B 0.00
MyoKardia (MYOK) United States $2.284B 0.00
Akcea Therapeutics (AKCA) United States $2.129B 0.00
Medicines (MDCO) United States $2.073B 0.00
Arena Pharmaceuticals (ARNA) United States $2.049B 0.00
REGENXBIO (RGNX) United States $2.009B 31.57
Cambrex (CBM) United States $1.995B 16.00
AnaptysBio (ANAB) United States $1.953B 0.00
Spark Therapeutics (ONCE) United States $1.908B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.888B 0.00
Reata Pharmaceuticals (RETA) United States $1.887B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.869B 0.00
Global Blood Therapeutics (GBT) United States $1.845B 0.00
Atara Biotherapeutics (ATRA) United States $1.739B 0.00
Denali Therapeutics (DNLI) United States $1.697B 0.00
Aimmune Therapeutics (AIMT) United States $1.654B 0.00
Clovis Oncology (CLVS) United States $1.607B 0.00
Puma Biotechnology (PBYI) United States $1.607B 0.00
Allakos (ALLK) United States $1.575B 0.00
Innoviva (INVA) United States $1.568B 10.06
Myovant Sciences (MYOV) United Kingdom $1.542B 0.00
G1 THERAPEUTICS (GTHX) United States $1.529B 0.00
Sangamo Therapeutics (SGMO) United States $1.504B 0.00
Rubius Therapeutics (RUBY) United States $1.467B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.440B 0.00
WAVE Life Sciences (WVE) Singapore $1.434B 0.00
Mirati Therapeutics (MRTX) United States $1.423B 0.00
Editas Medicine (EDIT) United States $1.385B 0.00
Insmed (INSM) United States $1.349B 0.00
Solid Biosciences (SLDB) United States $1.266B 0.00
IMMURON LTD (IMRN) Australia $1.186B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.174B 2242.00
Cellectis (CLLS) France $1.157B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.152B 0.00
NeoGenomics (NEO) United States $1.145B 200.29
Adaptimmune Therapeutics (ADAP) United Kingdom $1.119B 0.00
DBV Technologies (DBVT) France $1.100B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.098B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.083B 0.00
Intra-Cellular Therapies (ITCI) United States $1.073B 0.00
UniQure (QURE) Netherlands $1.073B 0.00
Lion Biotechnologies (IOVA) United States $1.071B 0.00
Retrophin (RTRX) United States $1.063B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.058B 0.00
Audentes Therapeutics (BOLD) United States $1.051B 0.00
Athenex (ATNX) United States $0.975B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.971B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.961B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.957B 0.00
Acorda Therapeutics (ACOR) United States $0.944B 19.69
Apellis Pharmaceuticals (APLS) United States $0.935B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.933B 0.00
Viking Therapeutics (VKTX) United States $0.926B 0.00
Revance Therapeutics (RVNC) United States $0.918B 0.00
Coherus BioSciences (CHRS) United States $0.907B 0.00
Aptinyx (APTX) United States $0.894B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.833B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.828B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.816B 0.00
InflaRx (IFRX) Germany $0.816B 0.00
Cara Therapeutics (CARA) United States $0.812B 0.00
Fate Therapeutics (FATE) United States $0.778B 0.00
Novavax (NVAX) United States $0.777B 0.00
CytomX Therapeutics (CTMX) United States $0.763B 0.00
Heska (HSKA) United States $0.745B 64.07
Epizyme (EPZM) United States $0.742B 0.00
Dynavax Technologies (DVAX) United States $0.723B 0.00
AVROBIO (AVRO) United States $0.697B 0.00
Mesoblast (MESO) Australia $0.695B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.694B 0.00
ANI Pharmaceuticals (ANIP) United States $0.666B 13.18
ObsEva SA (OBSV) Switzerland $0.629B 0.00
AC Immune SA (ACIU) Switzerland $0.626B 0.00
Anika Therapeutics (ANIK) United States $0.616B 25.90
Kura Oncology (KURA) United States $0.603B 0.00
UROGEN PHARMA (URGN) Israel $0.596B 0.00
MiMedx (MDXG) United States $0.590B 25.29
NuCana Sponsored ADR (NCNA) United Kingdom $0.587B 0.00
Principia Biopharma (PRNB) United States $0.562B 0.00
Arcus Biosciences (RCUS) United States $0.561B 0.00
Aduro Biotech (ADRO) United States $0.540B 0.00
Vericel (VCEL) United States $0.538B 0.00
UNITY Biotechnology (UBX) $0.534B 0.00
RA PHARMCTL INC (RARX) United States $0.525B 0.00
Prothena (PRTA) Ireland $0.520B 0.00
Inovio Pharmaceuticals (INO) United States $0.511B 0.00
Abeona Therapeutics (ABEO) United States $0.501B 0.00
ARVINAS INC (ARVN) United States $0.497B 0.00
Five Prime Therapeutics (FPRX) United States $0.495B 0.00
Stemline Therapeutics (STML) United States $0.493B 0.00
Senesco Technologies (ELOX) United States $0.488B 0.00
MediciNova (MNOV) United States $0.479B 0.00
Cytokineticsorporated (CYTK) United States $0.473B 0.00
Scholar Rock Holding (SRRK) United States $0.462B 0.00
Verastem (VSTM) United States $0.448B 0.00
Liquidia Technologies (LQDA) United States $0.445B 0.00
Kindred Biosciences (KIN) United States $0.443B 0.00
Zymeworks (ZYME) Canada $0.442B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.438B 0.00
Kezar Life Sciences (KZR) United States $0.434B 0.00
BeyondSpring (BYSI) United States $0.434B 0.00
Zealand Pharma (ZEAL) Denmark $0.432B 0.00
Sorrento Therapeutics (SRNE) United States $0.430B 73.60
UROVANT SCIENCS (UROV) United States $0.420B 0.00
Sinovac Biotech (SVA) China $0.415B 0.00
Replimune (REPL) United States $0.414B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.411B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.396B 0.00
PDL BioPharma (PDLI) United States $0.381B 5.35
MeiraGTx Holdings (MGTX) United States $0.380B 0.00
Merus (MRUS) Netherlands $0.371B 0.00
KODIAK SCIENCES (KOD) United States $0.365B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
GRITSTONE ONCLG (GRTS) United States $0.360B 0.00
Osiris Therapeutics (OSIR) United States $0.359B 0.00
ResTORbio (TORC) United States $0.349B 0.00
Eidos Therapeutics (EIDX) United States $0.345B 0.00
Albireo Pharma (ALBO) United States $0.340B 0.00
Geron (GERN) United States $0.338B 0.00
Kala Pharmaceuticals (KALA) United States $0.330B 0.00
Selecta Biosciences (SELB) United States $0.329B 0.00
SUTRO BIOPHARMA (STRO) United States $0.329B 0.00
Adverum Biotechnologies (ADVM) United States $0.327B 0.00
Kadmon Holdings (KDMN) United States $0.327B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.326B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.326B 0.00
Magenta Therapeutics (MGTA) United States $0.325B 0.00
Cellular Biomedicine (CBMG) United States $0.307B 0.00
Evelo Biosciences (EVLO) United States $0.306B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.306B 0.00
Athersys (ATHX) United States $0.298B 0.00
Axovant Sciences (AXON) United Kingdom $0.298B 0.00
Unum Therapeutics (UMRX) United States $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
MannKind (MNKD) United States $0.294B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.292B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.283B 0.00
BioTime (BTX) United States $0.277B 0.00
NantKwest (NK) United States $0.276B 0.00
Celcuity (CELC) United States $0.274B 0.00
Seres Therapeutics (MCRB) United States $0.274B 0.00
Krystal Biotech (KRYS) United States $0.272B 0.00
Celyad SA (CYAD) Belgium $0.271B 0.00
TOCAGEN INC (TOCA) United States $0.268B 0.00
Synlogic (SYBX) United States $0.265B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.260B 0.00
Arbutus Biopharma (ABUS) Canada $0.258B 0.00
Syros Pharmaceuticals (SYRS) United States $0.256B 0.00
ADMA Biologics Inc (ADMA) United States $0.245B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.244B 0.00
Strongbridge Biopharma (SBBP) United States $0.239B 0.00
Kamada (KMDA) Israel $0.238B 18.50
Idera Pharmaceuticals (IDRA) United States $0.238B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.234B 0.00
Protagonist Therapeutics (PTGX) United States $0.230B 0.00
Agenus (AGEN) United States $0.224B 0.00
BioDelivery Sciences (BDSI) United States $0.223B 0.00
Allena Pharmaceuticals (ALNA) United States $0.222B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.221B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.214B 0.00
ChromaDex (CDXC) United States $0.207B 0.00
Mersana Therapeutics (MRSN) United States $0.197B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.193B 0.00
Palatin Technologies (PTN) United States $0.190B 7.83
Clearside Biomedical (CLSD) United States $0.187B 0.00
Cerecor (CERC) United States $0.186B 19.04
Compugen (CGEN) Israel $0.185B 0.00
Enzo Biochem (ENZ) United States $0.184B 0.00
Cohbar (CWBR) United States $0.180B 0.00
CorMedix Inc (CRMD) United States $0.180B 0.00
Constellation Pharmaceuticals (CNST) United States $0.177B 0.00
PSivida (EYPT) United States $0.172B 0.00
Intec Pharma (NTEC) Israel $0.166B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.164B 0.00
Signal Genetics (MGEN) United States $0.160B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.159B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.155B 0.00
Spero Therapeutics (SPRO) United States $0.155B 0.00
Cue Biopharma (CUE) United States $0.151B 0.00
Menlo Therapeutics (MNLO) United States $0.150B 0.00
OVID THERAPEUTC (OVID) United States $0.149B 0.00
Pfenex (PFNX) United States $0.144B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.141B 0.00
Mustang Bio (MBIO) United States $0.140B 0.00
VBI Vaccines (VBIV) United States $0.140B 0.00
Monster Digital (INNT) United States $0.138B 0.00
Eleven Biotherapeutics (SESN) United States $0.137B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
XOMA (XOMA) United States $0.135B 14.24
XBiotech (XBIT) United States $0.130B 0.00
Provention Bio (PRVB) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.126B 0.00
Organovo Holdings (ONVO) United States $0.125B 0.00
Applied Genetic Technologies (AGTC) United States $0.123B 0.00
Motif Bio Plc (MTFB) United States $0.120B 0.00
ITUS (ANIX) United States $0.119B 0.00
Anavex Life Sciences (AVXL) United States $0.114B 0.00
Tapimmune (TPIV) United States $0.114B 0.00
Cidara Therapeutics (CDTX) United States $0.111B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.106B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.102B 0.00
Cel-Sci (CVM) United States $0.100B 0.00
Aptevo Therapeutics (APVO) United States $0.100B 0.00
VolitionRX (VNRX) Singapore $0.099B 0.00
VTv Therapeutics (VTVT) United States $0.098B 0.00
ScPharmaceuticals (SCPH) United States $0.098B 0.00
BioXcel Therapeutics (BTAI) United States $0.098B 0.00
Neothetics (EVFM) United States $0.098B 0.00
Leap Therapeutics (LPTX) United States $0.097B 0.00
Orgenesis (ORGS) United States $0.095B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.093B 0.00
Axsome Therapeutics (AXSM) United States $0.092B 0.00
Checkpoint Therapeutics (CKPT) United States $0.092B 0.00
Chiasma (CHMA) United States $0.090B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.088B 0.00
Protalix BioTherapeutics (PLX) Israel $0.087B 0.00
Aptose Biosciences (APTO) Canada $0.086B 0.00
Prima BioMed (IMMP) Australia $0.086B 0.00
NewLink Genetics (NLNK) United States $0.084B 0.00
Ophthotech (OPHT) United States $0.084B 0.54
OncoSec Medical (ONCS) United States $0.083B 0.00
Trevena (TRVN) United States $0.081B 0.00
Cocrystal Pharma (COCP) United States $0.081B 0.00
Sophiris Bio (SPHS) United States $0.075B 0.00
Celldex Therapeutics (CLDX) United States $0.074B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.073B 0.00
Curis (CRIS) United States $0.072B 0.00
Alimera Sciences (ALIM) United States $0.071B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.070B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Fortress Biotech (FBIO) United States $0.070B 0.00
Proteostasis Therapeutics (PTI) United States $0.070B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.068B 0.00
BIONANO GENOMIC (BNGO) United States $0.068B 0.00
Entera Bio (ENTX) Israel $0.064B 0.00
Oncobiologics (ONS) United States $0.063B 0.00
Bellerophon Therapeutics (BLPH) United States $0.062B 0.00
Asterias Biotherapeutics (AST) United States $0.059B 0.00
VistaGen Therapeutics (VTGN) United States $0.058B 0.00
Oncolytics Biotech (ONCY) Canada $0.057B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Zosano Pharma (ZSAN) United States $0.048B 0.00
TRACON Pharmaceuticals (TCON) United States $0.048B 0.00
Celsion (CLSN) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.047B 0.00
GTx (GTXI) United States $0.045B 0.00
Caladrius Biosciences (CLBS) United States $0.044B 0.00
AZURRX BIOPHARM (AZRX) United States $0.042B 0.00
Aileron Therapeutics (ALRN) United States $0.041B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
Advaxis (ADXS) United States $0.038B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
BioPharmX (BPMX) United States $0.035B 0.00
Galena Biopharma (SLS) United States $0.033B 0.00
Proteon Therapeutics (PRTO) United States $0.031B 0.00
CytRx (CYTR) United States $0.028B 0.00
Vical (VICL) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
OvaScience (OVAS) United States $0.027B 0.00
Cellect Biotechnology (APOP) Israel $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Edge Therapeutics (EDGE) United States $0.026B 0.00
AEterna Zentaris (AEZS) United States $0.025B 51.33
Gemphire Therapeutics (GEMP) United States $0.024B 0.00
Arsanis (ASNS) United States $0.023B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
Novelion Therapeutics (NVLN) Canada $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Histogenics (HSGX) United States $0.020B 0.00
RestorGenex (DFFN) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Soligenix (SNGX) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.018B 0.00
Therapix Biosciences (TRPX) Israel $0.017B 6.31
Adial Pharmaceuticals (ADIL) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
IBio (IBIO) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Neuralstem (CUR) United States $0.015B 0.00
Oragenics (OGEN) United States $0.013B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Cerulean Pharma (DARE) United States $0.013B 0.00
Flex Pharma (FLKS) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.011B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.007B 0.00
AmpliPhi Biosciences (APHB) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.002B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00